A) Full-dose RSI protocol | ||||
Baseline | Procedural | Absolute difference (95% CI) | P -value | |
Group 1 | ||||
Heart rate, bpma | 89 (72 to 104) | 111 (98 to 132) | 22 (14 to 38) | <0.0001 |
Mean arterial pressure, mmHgb | 98 (90 to 108) | 128 (113 to 145) | 31 (15 to 48) | <0.0001 |
Systolic blood pressure, mmHgb | 129 (114 to 144) | 170 (151 to 196) | 44 (22 to 61) | <0.0001 |
Group 2 | ||||
Heart rate, bpmc | 87 (74 to 101) | 112 (97 to 125) | 25 (18 to 30) | <0.0001 |
Mean arterial pressure, mmHgd | 102 (90 to 113) | 107 (91 to 121) | 5 (−1 to 10) | 0.148 |
Systolic blood pressure, mmHgd | 133 (120 to 149) | 140 (120 to 155) | 7 (−3 to 11) | 0.257 |
B) Reduced-dose protocol | ||||
Baseline | Procedural | Absolute difference (95% CI) | P -value | |
Group 1 | ||||
Heart rate, bpme | 107 (84 to 121) | 122 (111 to 137) | 15 (4 to 27) | 0.009 |
Mean arterial pressure, mmHgf | 79 (54 to 95) | 99 (78 to 117) | 20 (6 to 36) | 0.004 |
Systolic blood pressure, mmHgf | 100 (71 to 115) | 129 (100 to 147) | 29 (13 to 48) | 0.001 |
Group 2 | ||||
Heart rate, bpmg | 106 (91 to 131) | 123 (105 to 143) | 17 (−2 to 28) | 0.095 |
Mean arterial pressure, mmHgf | 95 (70 to 109) | 101 (89 to 126) | 6 (−3 to 28) | 0.117 |
Systolic blood pressure, mmHgf | 117 (104 to 145) | 129 (110 to 149) | 9 (−7 to 28) | 0.256 |